We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.

Cell | Nov 17, 2006

Spinocerebellar ataxia type 1 (SCA1) is one of nine inherited, typically adult onset, polyglutamine neurodegenerative diseases. To examine whether development impacts SCA1, we used a conditional transgenic mouse model of SCA1 to delay the postnatal expression of mutant ATXN1 until after completion of cerebellar development. Delayed postnatal expression of mutant ATXN1 led to a substantial reduction in severity of disease in adults in comparison with early postnatal gene expression. This was linked to a destabilization of RORalpha, a transcription factor critical for cerebellar development. In SCA1 mice, there was a depletion of RORalpha and a reduction in expression of genes controlled by RORalpha. Partial loss of RORalpha enhanced mutant ATXN1 pathogenicity. Additionally, evidence points to the existence of a complex containing ATXN1, RORalpha, and the RORalpha coactivator Tip60. These studies indicate RORalpha and Tip60 have a role in SCA1 and suggest a mechanism by which compromising cerebellar development contributes to severity of neurodegeneration in an adult.

Pubmed ID: 17110330 RIS Download

Mesh terms: Animals | Ataxin-1 | Ataxins | COS Cells | Cercopithecus aethiops | Disease Progression | Down-Regulation | Histone Acetyltransferases | Humans | Mice | Mice, Neurologic Mutants | Mice, Transgenic | Mutant Proteins | Nerve Tissue Proteins | Nuclear Proteins | Nuclear Receptor Subfamily 1, Group F, Member 1 | Protein Binding | Protein Interaction Mapping | Purkinje Cells | RNA, Messenger | Receptors, Cytoplasmic and Nuclear | Trans-Activators

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, Id: NS22920
  • Agency: NINDS NIH HHS, Id: NS27699
  • Agency: NINDS NIH HHS, Id: NS45667

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.